Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node...

Area of Science:

• Oncology
• Urology
• Surgical Pathology

Background:

• Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) is a critical component in managing advanced testicular cancer.
• Nephrectomy during PC-RPLND, while sometimes necessary, carries significant morbidity.
• Understanding the factors influencing the decision for nephrectomy is crucial for optimizing patient outcomes.

Purpose of the Study:

• To identify clinical and pathological features associated with performing nephrectomy during PC-RPLND.
• To analyze trends in nephrectomy rates over time.
• To determine predictors of nephrectomy in patients undergoing PC-RPLND for testicular cancer.

Main Methods:

• Retrospective review of a testis cancer database (1980-2007).
• Inclusion of 1,807 patients treated with PC-RPLND (excluding pure seminoma and non-germ cell histology).
• Bivariate and multivariate logistic regression analyses to assess predictors of nephrectomy.

Main Results:

• Overall nephrectomy incidence was 14.8%, showing a significant decrease over the study period (p=0.0001).
• Nephrectomy rates increased with retroperitoneal mass size, particularly for masses >10 cm (OR 9.30).
• Higher incidence of nephrectomy was associated with teratoma and cancer histology compared to fibrosis (p=0.0001).

Conclusions:

• The rate of nephrectomy during PC-RPLND has declined significantly over three decades.
• Large retroperitoneal tumor size is the strongest predictor for nephrectomy.
• Factors such as salvage chemotherapy, left-sided primary tumors, and elevated post-chemotherapy markers also influence nephrectomy rates.